This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
amino acid | 499 |
infected cells | 408 |
respiratory syndrome | 371 |
infectious bronchitis | 370 |
porcine epidemic | 334 |
epidemic diarrhea | 314 |
bronchitis virus | 308 |
diarrhea virus | 277 |
influenza virus | 268 |
per cent | 265 |
cell culture | 247 |
viral rna | 235 |
hepatitis virus | 232 |
arch virol | 218 |
mouse hepatitis | 217 |
doc id | 216 |
virol doi | 216 |
cord uid | 216 |
virus infection | 212 |
porcine reproductive | 203 |
phylogenetic analysis | 201 |
amino acids | 198 |
transmissible gastroenteritis | 188 |
feline infectious | 185 |
infectious peritonitis | 184 |
respiratory tract | 177 |
present study | 175 |
syndrome virus | 170 |
nucleotide sequence | 170 |
structural proteins | 170 |
disease virus | 168 |
described previously | 163 |
monoclonal antibodies | 163 |
acute respiratory | 161 |
virus replication | 158 |
vero cells | 153 |
sequence analysis | 144 |
cell line | 144 |
closely related | 140 |
gastroenteritis virus | 139 |
avian infectious | 133 |
clinical signs | 131 |
virus particles | 130 |
bovine coronavirus | 130 |
cell cultures | 126 |
influenza viruses | 126 |
performed using | 124 |
antibody titers | 123 |
electron microscopy | 122 |
pcr products | 122 |
united states | 121 |
antiviral activity | 119 |
middle east | 119 |
respiratory viruses | 119 |
rna viruses | 113 |
pcr assay | 112 |
chain reaction | 112 |
ibv strains | 111 |
cell lines | 110 |
acid sequence | 109 |
polymerase chain | 108 |
spike protein | 107 |
ibv isolates | 107 |
tissue culture | 107 |
previously described | 107 |
virus strain | 101 |
sequence identity | 100 |
reverse transcription | 100 |
nucleotide sequences | 99 |
pdcov oh | 97 |
cell fusion | 96 |
acid sequences | 95 |
room temperature | 95 |
fecal samples | 94 |
immune response | 93 |
time rt | 93 |
three times | 93 |
virus type | 92 |
viral replication | 92 |
neutralizing antibodies | 92 |
serum samples | 91 |
field isolates | 91 |
severe acute | 90 |
infectious virus | 90 |
peritonitis virus | 89 |
syndrome coronavirus | 89 |
viral infection | 88 |
per ml | 87 |
mouth disease | 87 |
herpes simplex | 87 |
fever virus | 86 |
prrsv infection | 86 |
phylogenetic tree | 85 |
viral antigen | 84 |
genome sequence | 84 |
nucleocapsid protein | 84 |
vaccine strain | 84 |
complete genome | 83 |
virus strains | 82 |
simplex virus | 80 |
bf sha | 80 |
nucleic acid | 80 |
canine parvovirus | 79 |
bovine serum | 79 |
like particles | 79 |
movement proteins | 79 |
binding domain | 79 |
epithelial cells | 78 |
human metapneumovirus | 78 |
stranded rna | 78 |
cells infected | 77 |
cell surface | 76 |
time pcr | 75 |
cleavage site | 75 |
positive samples | 74 |
neutralizing antibody | 74 |
coding region | 74 |
immune responses | 73 |
monoclonal antibody | 73 |
virus entry | 73 |
previous studies | 72 |
molecular characterization | 72 |
genetic diversity | 72 |
mosaic virus | 71 |
agarose gel | 71 |
gel electrophoresis | 71 |
viral infections | 70 |
type i | 70 |
infected cell | 70 |
alveolar macrophages | 69 |
genomic rna | 69 |
western blot | 68 |
protein synthesis | 68 |
cytopathic effect | 68 |
highly conserved | 68 |
korean ibv | 68 |
south korea | 68 |
hemorrhagic fever | 67 |
open reading | 67 |
canine coronavirus | 67 |
rna binding | 66 |
porcine deltacoronavirus | 66 |
total rna | 65 |
sequence similarity | 65 |
vesicular stomatitis | 65 |
reverse transcriptase | 65 |
host cell | 65 |
spleen cells | 65 |
viral dna | 64 |
infected mice | 63 |
stomatitis virus | 63 |
mg ml | 63 |
viral proteins | 63 |
st cells | 63 |
respiratory disease | 62 |
murine coronavirus | 62 |
buffered saline | 61 |
strand rna | 61 |
eya virus | 61 |
calf diarrhea | 60 |
east respiratory | 60 |
rna polymerase | 60 |
human coronavirus | 60 |
avian influenza | 59 |
viral protein | 59 |
small intestine | 59 |
phylogenetic trees | 59 |
supplementary material | 58 |
gene expression | 58 |
mm tris | 58 |
vaccine strains | 57 |
virus isolation | 57 |
cell monolayers | 57 |
pedv infection | 57 |
respiratory syncytial | 56 |
molecular weight | 56 |
viral particles | 56 |
clinical samples | 56 |
molecular epidemiology | 56 |
negative control | 56 |
mouse igg | 56 |
plaque assay | 56 |
bursal disease | 55 |
well plates | 55 |
orf gene | 54 |
enteric coronavirus | 54 |
interferon induction | 54 |
porcine parvovirus | 54 |
movement protein | 54 |
syncytial virus | 53 |
virus isolates | 53 |
parainfluenza virus | 53 |
host cells | 53 |
infectious bursal | 53 |
structural protein | 53 |
gene sequences | 53 |
recombination events | 53 |
important role | 53 |
reference strains | 52 |
results showed | 52 |
capsid protein | 52 |
binding activity | 52 |
genbank accession | 51 |
equine arteritis | 51 |
specific igg | 51 |
calf serum | 51 |
tcov isolates | 51 |
antiviral effect | 51 |
virus titers | 51 |
antigenic relationship | 50 |
fusion activity | 50 |
cell lysates | 50 |
fipv infection | 50 |
viral genome | 50 |
tract infections | 50 |
mouse brain | 50 |
virus rna | 50 |
dub activity | 49 |
genbank database | 49 |
peripheral blood | 49 |
infected pigs | 48 |
newcastle disease | 48 |
arteritis virus | 48 |
type ii | 48 |
upper respiratory | 48 |
spike glycoprotein | 48 |
goat anti | 48 |
rna virus | 48 |
human adenovirus | 47 |
experimental infection | 47 |
washed three | 47 |
virus infections | 47 |
ctf virus | 47 |
essential medium | 47 |
accession numbers | 47 |
prrsv replication | 46 |
lg ml | 46 |
results suggest | 46 |
pedv strains | 46 |
clinical disease | 46 |
rna synthesis | 46 |
significantly higher | 46 |
rna genome | 46 |
genome sequences | 46 |
two viruses | 46 |
protein gene | 46 |
fip cats | 46 |
ck ch | 45 |
viruses isolated | 45 |
field strains | 45 |
family coronaviridae | 45 |
mrna expression | 45 |
lamp assay | 45 |
nucleic acids | 45 |
purified using | 44 |
treated cells | 44 |
mice infected | 44 |
feline coronavirus | 43 |
antibody responses | 43 |
analyzed using | 43 |
acute gastroenteritis | 43 |
hong kong | 43 |
fetal bovine | 43 |
rna recombination | 43 |
adenovirus type | 43 |
plasma membrane | 43 |
sequence alignment | 42 |
positive cells | 42 |
sequence data | 42 |
applied biosystems | 42 |
chicken erythrocytes | 42 |
infant mice | 42 |
respiratory coronavirus | 42 |
fusion protein | 42 |
pandemic influenza | 41 |
virus isolated | 41 |
pcr assays | 41 |
target cells | 41 |
statistically significant | 41 |
coronavirus infection | 41 |
minute virus | 41 |
vp gene | 41 |
lower respiratory | 41 |
congo hemorrhagic | 41 |
mouse spleen | 41 |
dependent rna | 40 |
membrane fusion | 40 |
nasal swabs | 40 |
protein genes | 40 |
determined using | 40 |
pedv field | 40 |
suckling mouse | 40 |
blot analysis | 40 |
purified virus | 40 |
accession number | 40 |
culture fluid | 40 |
washed twice | 40 |
previous study | 40 |
respiratory virus | 40 |
culture medium | 39 |
swab samples | 39 |
endoplasmic reticulum | 39 |
reading frame | 39 |
suckling mice | 39 |
samples collected | 39 |
vp protein | 39 |
glycosylation sites | 39 |
results indicate | 38 |
medium containing | 38 |
two different | 38 |
virus attachment | 38 |
significant difference | 38 |
gnotobiotic pigs | 38 |
fluorescent antibody | 38 |
dna vaccine | 38 |
expression levels | 38 |
antigenically related | 38 |
may also | 38 |
sequence alignments | 38 |
syncytium formation | 38 |
experimentally infected | 37 |
protein expression | 37 |
feline coronaviruses | 37 |
like agent | 37 |
dengue virus | 37 |
positive control | 37 |
chimeric vlps | 36 |
molecular evolutionary | 36 |
polyacrylamide gel | 36 |
genome organization | 36 |
multiplex pcr | 36 |
previously reported | 36 |
differentially expressed | 36 |
indirect immunofluorescence | 36 |
nitric oxide | 36 |
receptor binding | 36 |
technical assistance | 36 |
innate immune | 36 |
days post | 36 |
interferon production | 36 |
reading frames | 35 |
pfu ml | 35 |
kindly provided | 35 |
determine whether | 35 |
kidney cells | 35 |
rna extraction | 35 |
neonatal calf | 35 |
inoculated pigs | 35 |
cultured cells | 35 |
rna degradation | 35 |
viral antigens | 35 |
complete nucleotide | 35 |
molecular biology | 35 |
fetal calf | 35 |
coronavirus spike | 35 |
time points | 35 |
culture supernatant | 35 |
dna polymerase | 35 |
porcine respiratory | 34 |
highly pathogenic | 34 |
proteolytic cleavage | 34 |
current study | 34 |
control group | 34 |
economic losses | 34 |
bhk cells | 34 |
immunodeficiency virus | 34 |
viral entry | 34 |
virus titer | 34 |
inhibitory effect | 34 |
dna synthesis | 33 |
dbt cells | 33 |
immunosorbent assay | 33 |
causative agent | 33 |
also observed | 33 |
thank dr | 33 |
trypsin treatment | 33 |
adult cattle | 33 |
virus neutralization | 33 |
electron microscope | 33 |
porcine circovirus | 33 |
akt pathway | 33 |
igg antibody | 33 |
pcr amplification | 33 |
lymph nodes | 33 |
fecal specimens | 33 |
marc cells | 33 |
respiratory distress | 33 |
bcv strains | 33 |
pcr using | 32 |
neutralizing epitopes | 32 |
frhk cells | 32 |
deduced amino | 32 |
reported previously | 32 |
linked immunosorbent | 32 |
rotavirus infection | 32 |
pedv strain | 32 |
asthma exacerbations | 32 |
emc virus | 32 |
tcid ml | 32 |
rna replication | 32 |
coat protein | 32 |
coronavirus ibv | 32 |
western blotting | 32 |
surface projections | 32 |
electron microscopic | 31 |
hypervariable region | 31 |
progeny virus | 31 |
cellular cholesterol | 31 |
analysis showed | 31 |
pedv isolates | 31 |
clinical symptoms | 31 |
antibody response | 31 |
like virus | 31 |
igg antibodies | 31 |
one day | 31 |
data suggest | 31 |
virus genome | 31 |
multiple sequence | 31 |
dendritic cells | 31 |
novel coronavirus | 31 |
respiratory infections | 31 |
gn pigs | 31 |
viral envelope | 31 |
sialic acid | 31 |
cellular receptor | 31 |
watery diarrhea | 30 |
rabbit anti | 30 |
acid residues | 30 |
authors declare | 30 |
terminal region | 30 |
online version | 30 |
virus production | 30 |
acid changes | 30 |
sense rna | 30 |
international committee | 30 |
two isolates | 30 |
minimum essential | 30 |
culture supernatants | 30 |
dependent manner | 30 |
contains supplementary | 30 |
sendai virus | 30 |
strains isolated | 30 |
high levels | 30 |
analysis based | 30 |
pcr product | 30 |
also detected | 30 |
bovine torovirus | 30 |
joining method | 30 |
authorized users | 30 |
avian coronavirus | 29 |
gg ml | 29 |
age groups | 29 |
porcine nidovirus | 29 |
serum albumin | 29 |
virus suspension | 29 |
public health | 29 |
pcr method | 29 |
three different | 29 |
pedv vaccine | 29 |
genetics analysis | 29 |
respiratory infection | 29 |
length genome | 29 |
culture plates | 29 |
evolutionary genetics | 29 |
measles virus | 29 |
semliki forest | 28 |
extraction kit | 28 |
equal volume | 28 |
capsid proteins | 28 |
mm edta | 28 |
expressed genes | 28 |
neutralizing activity | 28 |
large number | 28 |
mhv strains | 28 |
electronic supplementary | 28 |
lactate dehydrogenase | 28 |
also showed | 28 |
infectious diseases | 28 |
results indicated | 28 |
molecular cloning | 28 |
ammonium chloride | 28 |
fusion proteins | 28 |
gene sequence | 28 |
two groups | 28 |
kda protein | 28 |
taken together | 28 |
clinical specimens | 28 |
also found | 28 |
neonatal piglets | 28 |
pk cells | 28 |
rna probes | 28 |
human cytomegalovirus | 28 |
american type | 27 |
canine distemper | 27 |
survival factors | 27 |
fipv strain | 27 |
hepatitis delta | 27 |
human immunodeficiency | 27 |
mononuclear cells | 27 |
membrane protein | 27 |
tissue tropism | 27 |
secondary structure | 27 |
gibco brl | 27 |
assisted rt | 27 |
first detected | 27 |
major structural | 27 |
dna replication | 27 |
molecular weights | 27 |
simultaneous detection | 27 |
mouse erythrocytes | 27 |
serial dilutions | 27 |
i na | 27 |
tract infection | 27 |
intestinal contents | 26 |
stop codon | 26 |
serum antibody | 26 |
culture fluids | 26 |
sequence homology | 26 |
neutralization test | 26 |
pbs containing | 26 |
high mortality | 26 |
intestinal epithelial | 26 |
i fragment | 26 |
binding protein | 26 |
coding regions | 26 |
glycoprotein gene | 26 |
serum dilution | 26 |
antigenic sites | 26 |
specific antibodies | 26 |
feline macrophages | 26 |
central china | 26 |
type culture | 26 |
bat ace | 26 |
final concentration | 26 |
protein sequences | 26 |
bone marrow | 26 |
mouse brains | 26 |
spf cats | 26 |
elevating virus | 26 |
persistent infection | 26 |
severe diarrhea | 26 |
gene encoding | 26 |
virus shedding | 26 |
hmg box | 26 |
described elsewhere | 25 |
virus neutralizing | 25 |
like protease | 25 |
nested pcr | 25 |
lbc cells | 25 |
viral glycoproteins | 25 |
culture collection | 25 |
lymph node | 25 |
calculated using | 25 |
i i | 25 |
rectal swabs | 25 |
protein binding | 25 |
recent studies | 25 |
genetic groups | 25 |
similar results | 25 |
belgorod dom | 25 |
cell membrane | 25 |
infected vero | 25 |
tested positive | 25 |
distilled water | 25 |
mers cov | 25 |
post infection | 25 |
virus glycoprotein | 25 |
recent years | 25 |
family reoviridae | 25 |
rat coronavirus | 25 |
inoculated onto | 25 |
pedv belgorod | 25 |
horseradish peroxidase | 25 |
acid identity | 25 |
secondary antibody | 25 |
salivary gland | 25 |
simple method | 25 |
recombinant plasmids | 25 |
days later | 25 |
porcine alveolar | 25 |
immunofluorescence assay | 25 |
situ hybridization | 25 |
life cycle | 25 |
crfk cells | 25 |
cells treated | 25 |
canine rotavirus | 25 |
hours post | 24 |
replication cycle | 24 |
escherichia coli | 24 |
core protein | 24 |
enteric viruses | 24 |
viral shedding | 24 |
mouse anti | 24 |
well tissue | 24 |
rhino entero | 24 |
untranslated region | 24 |
rv protease | 24 |
lysis buffer | 24 |
novel ibvs | 24 |
point mutations | 24 |
passive immunity | 24 |
genetic characterization | 24 |
encephalomyelitis virus | 24 |
knu cells | 24 |
indirect fluorescent | 24 |
natural host | 24 |
genomic sequences | 24 |
tree based | 24 |
pleural effusion | 24 |
ibv strain | 24 |
swine industry | 24 |
length polymorphism | 24 |
blood samples | 24 |
tobacco mosaic | 24 |
data indicate | 24 |
respiratory illness | 24 |
serially diluted | 24 |
antigenic relationships | 24 |
body weight | 24 |
forest virus | 24 |
enveloped viruses | 24 |
epidemic diarrhoea | 24 |
cell differentiation | 24 |
diarrhea coronavirus | 24 |
quantitative real | 24 |
rubella virus | 24 |
north america | 23 |
piglets born | 23 |
cleavage recognition | 23 |
iranian provinces | 23 |
specific primers | 23 |
relationships among | 23 |
chinese ibv | 23 |
study showed | 23 |
negative controls | 23 |
dependent enhancement | 23 |
mhv infection | 23 |
previous reports | 23 |
plant virus | 23 |
time reverse | 23 |
analysis using | 23 |
sodium dodecyl | 23 |
results obtained | 23 |
statistical analysis | 23 |
bat covs | 23 |
much higher | 23 |
north american | 23 |
vero cell | 23 |
feline enteric | 23 |
signaling pathway | 23 |
post inoculation | 23 |
iga antibodies | 23 |
winter dysentery | 23 |
genomic sequence | 23 |
breda virus | 23 |
nt sequence | 23 |
different strains | 23 |
sindbis virus | 23 |
adult patients | 23 |
highly contagious | 23 |
stranded dna | 23 |
schizophrenia patients | 23 |
detected using | 23 |
sample buffer | 23 |
three independent | 23 |
human influenza | 23 |
old spf | 23 |
hyperimmune serum | 23 |
using trizol | 23 |
recombinant plasmid | 23 |
like viruses | 23 |
sequence comparison | 23 |
canine coronaviruses | 23 |
mouse adenovirus | 23 |
ethical approval | 23 |
fragment length | 23 |
two distinct | 23 |
assay panel | 22 |
korean pedv | 22 |
delta virus | 22 |
three viruses | 22 |
extracted using | 22 |
even though | 22 |
parvovirus type | 22 |
biological properties | 22 |
protein kinase | 22 |
immune system | 22 |
different time | 22 |
restriction enzyme | 22 |
berne virus | 22 |
pcr kit | 22 |
apn cells | 22 |
hev igg | 22 |
polykaryon formation | 22 |
sars coronavirus | 22 |
reaction mixtures | 22 |
live vaccine | 22 |
murine norovirus | 22 |
pdcov strains | 22 |
distemper virus | 22 |
severe disease | 22 |
infected piglets | 22 |
like particle | 22 |
pseudorabies virus | 22 |
recombinant virus | 22 |
ebola virus | 22 |
encephalomyocarditis virus | 22 |
colorado tick | 22 |
adenovirus infection | 22 |
antibody titer | 22 |
negatively stained | 22 |
plasmid dna | 22 |
korean field | 22 |
murine hepatitis | 22 |
vereflu tm | 22 |
ascorbic acid | 22 |
final extension | 22 |
binding proteins | 22 |
thermo fisher | 22 |
conjugated anti | 22 |
three major | 22 |
tick fever | 22 |
rapid detection | 22 |
serial passages | 22 |
saudi arabia | 22 |
baff mrna | 22 |
envelope protein | 22 |
barr virus | 22 |
first report | 21 |
restriction fragment | 21 |
antibody levels | 21 |
dna vaccines | 21 |
mottle virus | 21 |
protease trans | 21 |
young children | 21 |
free medium | 21 |
fecal shedding | 21 |
recombinant strains | 21 |
infected animals | 21 |
phosphate buffered | 21 |
results show | 21 |
recombination regions | 21 |
mock infected | 21 |
bkov egy | 21 |
aa substitutions | 21 |
genetic analysis | 21 |
virus date | 21 |
maintenance medium | 21 |
plant viruses | 21 |
mvc strains | 21 |
examined using | 21 |
two weeks | 21 |
virus infectivity | 21 |
chicken eggs | 21 |
rflp analysis | 21 |
isothermal amplification | 21 |
nested rt | 21 |
nasopharyngeal swab | 21 |
viral diarrhea | 21 |
mm nacl | 21 |
hypervariable regions | 21 |
iu ml | 21 |
fold dilutions | 21 |
homologous virus | 21 |
binding sites | 21 |
sialodacryoadenitis virus | 21 |
coronavirus infections | 21 |
chinese strains | 21 |
plaque reduction | 21 |
dna sequence | 21 |
previous report | 21 |
protein sequence | 21 |
uninfected cells | 21 |
nude mice | 20 |
bovine enteric | 20 |
proteolytic processing | 20 |
basic amino | 20 |
nervous system | 20 |
blood cells | 20 |
respiratory pathogens | 20 |
binding reactions | 20 |
cells grown | 20 |
type virus | 20 |
mg kg | 20 |
microtiter plates | 20 |
cdna synthesis | 20 |
first reported | 20 |
protein species | 20 |
hydrophobic regions | 20 |
ethidium bromide | 20 |
rabies virus | 20 |
protein may | 20 |
fisher scientific | 20 |
prcv strains | 20 |
amplified using | 20 |
lelystad virus | 20 |
virus binding | 20 |
buffer containing | 20 |
polymerase gene | 20 |
coronavirus strain | 20 |
plaque formation | 20 |
bovine rotavirus | 20 |
fipv type | 20 |
state university | 20 |
persistently infected | 20 |
turkey coronavirus | 20 |
better understanding | 20 |
tissue homogenates | 20 |
randomly selected | 20 |
inhibitory effects | 20 |
like domain | 20 |
primer pairs | 20 |
nosocomial outbreaks | 20 |
antiviral effects | 20 |
monkey kidney | 20 |
orf genes | 20 |
consensus sequence | 20 |
viral titers | 20 |
virus detection | 20 |
effusion disease | 20 |
ep group | 20 |
human respiratory | 20 |
differentiation survival | 20 |
analysis revealed | 20 |
well plate | 20 |
hexon gene | 20 |
peplomer protein | 20 |
different species | 19 |
mediated isothermal | 19 |
acid substitutions | 19 |
guangdong province | 19 |
arg dq | 19 |
restriction enzymes | 19 |
mhv rna | 19 |
coronavirus strains | 19 |
viral genomic | 19 |
polyacrylamide gels | 19 |
early stage | 19 |
constructed using | 19 |
fecal sample | 19 |
gastroenteritis coronavirus | 19 |
mcmv infection | 19 |
red blood | 19 |
binding site | 19 |
lymphocyte proliferation | 19 |
viral infectivity | 19 |
trizol reagent | 19 |
continuous cell | 19 |
tm assay | 19 |
virus stocks | 19 |
virus movement | 19 |
start codon | 19 |
swine fetuses | 19 |
conjugated goat | 19 |
two pedv | 19 |
severe clinical | 19 |
per cell | 19 |
viral pathogens | 19 |
mdck cells | 19 |
conserved regions | 19 |
recognition site | 19 |
culture adapted | 19 |
growth medium | 19 |
virus antigen | 19 |
spike gene | 19 |
coronavirus infectious | 19 |
enteric disease | 19 |
bronchitis viruses | 19 |
antigenic variation | 19 |
using mega | 19 |
plasma cells | 19 |
suckling piglets | 19 |
feline alveolar | 19 |
porcine transmissible | 19 |
nitrocellulose membranes | 19 |
antiviral drugs | 19 |
agarose gels | 19 |
naturally occurring | 19 |
sjl mice | 19 |
structural polypeptides | 19 |
severe respiratory | 19 |
human adenoviruses | 19 |
viral nucleic | 19 |
hemagglutinating encephalomyelitis | 18 |
induce interferon | 18 |
hyperimmune sera | 18 |
kindly supplied | 18 |
superoxide radicals | 18 |
wasting syndrome | 18 |
clinical manifestations | 18 |
dna viruses | 18 |
new england | 18 |
detection limit | 18 |
virus adsorption | 18 |
cells may | 18 |
three groups | 18 |
lithium chloride | 18 |
group i | 18 |
nde i | 18 |
disease control | 18 |
significantly increased | 18 |
mm sodium | 18 |
sg mrna | 18 |
also present | 18 |
new coronavirus | 18 |
transmembrane segments | 18 |
ha titers | 18 |
high degree | 18 |
samples tested | 18 |
neutrophil survival | 18 |
widely used | 18 |
clone infected | 18 |
cell types | 18 |
several studies | 18 |
signaling pathways | 18 |
attenuated strains | 18 |
cell proliferation | 18 |
na gp | 18 |
newborn piglets | 18 |
amplified products | 18 |
protease activity | 18 |
integral membrane | 18 |
molecular detection | 18 |
cov infection | 18 |
different viruses | 18 |
influenza vaccine | 18 |
also tested | 18 |
balb mice | 18 |
crystal structure | 18 |
gene dna | 18 |
rectal swab | 18 |
vaccinia virus | 18 |
antibody titres | 18 |
family picornaviridae | 18 |
sentinel pigs | 18 |
expression level | 18 |
fluorescein isothiocyanate | 18 |
lopinavir ritonavir | 18 |
nonstructural proteins | 18 |
host range | 18 |
diarrhea viruses | 18 |
interstitial pneumonia | 18 |
significantly lower | 18 |
visualized using | 18 |
csf mrna | 18 |
monocytes macrophages | 18 |
domestic ducks | 18 |
rna probe | 18 |
dq ck | 18 |
complete orf | 18 |
attenuated vaccine | 17 |
viral titer | 17 |
mortality rates | 17 |
animal experiments | 17 |
clinical features | 17 |
tube assay | 17 |
conducted using | 17 |
animal species | 17 |
kun rna | 17 |
baby rabbits | 17 |
endothelial cells | 17 |
day pi | 17 |
murine coronaviruses | 17 |
minimal essential | 17 |
envelope glycoproteins | 17 |
modified live | 17 |
serum igg | 17 |
one hour | 17 |
viral polypeptides | 17 |
measured using | 17 |
first time | 17 |
polyclonal antibodies | 17 |
blood mononuclear | 17 |
national institute | 17 |
naturally infected | 17 |
log ge | 17 |
deletion mutants | 17 |
hela cells | 17 |
high prevalence | 17 |
highest dilution | 17 |
primers used | 17 |
acid mutations | 17 |
following infection | 17 |
ml streptomycin | 17 |
antigen positive | 17 |
bovine viral | 17 |
least one | 17 |
seasonal influenza | 17 |
human coronaviruses | 17 |
encoded protein | 17 |
detection rate | 17 |
crystal violet | 17 |
generated using | 17 |
reverse transcribed | 17 |
diarrhoea virus | 17 |
recombination among | 17 |
nidovirus infection | 17 |
specific pathogen | 17 |
day post | 17 |
junin virus | 17 |
two major | 17 |
pcr system | 17 |
extracellular virus | 17 |
lymphoid cells | 17 |
allantoic fluid | 17 |
virus types | 17 |
virus stock | 17 |
low ph | 17 |
severe pneumonia | 17 |
i site | 17 |
among different | 17 |
membrane glycoprotein | 17 |
cell lysate | 17 |
authors thank | 17 |
viruses belonging | 17 |
cell survival | 17 |
i interferon | 17 |
vaccine development | 17 |
alpha beta | 17 |
central nervous | 17 |
single stranded | 17 |
cell entry | 17 |
significant differences | 17 |
member viruses | 17 |
envelope glycoprotein | 17 |
infectious serum | 16 |
federal republic | 16 |
infected cultures | 16 |
clinical characteristics | 16 |
fold higher | 16 |
protein vp | 16 |
transcription polymerase | 16 |
foster city | 16 |
dodecyl sulfate | 16 |
mammalian cells | 16 |
cytopathic effects | 16 |
infected macrophages | 16 |
temperature sensitive | 16 |
cell epitopes | 16 |
human bocavirus | 16 |
cold pbs | 16 |
cdna probes | 16 |
chemical co | 16 |
nr mutants | 16 |
specific binding | 16 |
multiplex rt | 16 |
dna virus | 16 |
phylogenetic relationships | 16 |
wild birds | 16 |
mpcr method | 16 |
neutralization tests | 16 |
different types | 16 |
infectious agents | 16 |
respiratory viral | 16 |
conformational changes | 16 |
sequencing kit | 16 |
table shows | 16 |
years old | 16 |
leukemia virus | 16 |
ml penicillin | 16 |
like receptor | 16 |
new genus | 16 |
santa cruz | 16 |
ns protein | 16 |
animal health | 16 |
mm nac | 16 |
genotype iii | 16 |
encephalitis virus | 16 |
glial cells | 16 |
spf chickens | 16 |
porcine nidoviruses | 16 |
type infection | 16 |
tat tac | 16 |
highest serum | 16 |
significant economic | 16 |
positive rate | 16 |
ha titer | 16 |
guinea pig | 16 |
virus glycoproteins | 16 |
flow cytometry | 16 |
deltacoronavirus strain | 16 |
adult cows | 16 |
linked glycosylation | 16 |
recombination within | 16 |
villous atrophy | 16 |
infectious dose | 16 |
specific primer | 16 |
independent fusion | 16 |
genetic variant | 16 |
sequence variation | 16 |
specific antibody | 16 |
cellular rna | 16 |
human participants | 16 |
genetic relationship | 16 |
strain fr | 16 |
remains unclear | 16 |
matrix protein | 16 |
poultry industry | 16 |
tract disease | 16 |
purification kit | 16 |
veterinary medicine | 16 |
binding assay | 16 |
biological activities | 16 |
order nidovirales | 16 |
graphpad prism | 16 |
salivary glands | 16 |
likelihood method | 16 |
tissue samples | 16 |
clinical diagnosis | 16 |
comparative analysis | 16 |
independent experiments | 16 |
three isolates | 16 |
kidney cell | 16 |
producing cells | 16 |
virus infected | 16 |
large amounts | 16 |
mm mgcl | 16 |
serial passage | 16 |
mice inoculated | 16 |
reference sequences | 16 |
fruit bats | 16 |
virus spike | 16 |
orf abc | 16 |
subgenomic mrnas | 16 |
using primers | 16 |
critical role | 16 |
life technologies | 16 |
reproductive failure | 16 |
assay using | 16 |
fecv strain | 16 |
different regions | 16 |
infant mouse | 16 |
th passage | 15 |
genetic variants | 15 |
rrna degradation | 15 |
complete sequence | 15 |
virus titres | 15 |
permissive cells | 15 |
nondenaturing gel | 15 |
canine adenovirus | 15 |
ifn gamma | 15 |
antibodies directed | 15 |
kd protein | 15 |
virulent pedv | 15 |
day old | 15 |
hours pi | 15 |
broadly reactive | 15 |
amino terminus | 15 |
unpublished results | 15 |
relatively low | 15 |
enveloped virus | 15 |
kakegawa strain | 15 |
reaction conditions | 15 |
fresh medium | 15 |
virus evolution | 15 |
necrosis factor | 15 |
inclusion bodies | 15 |
primary immunization | 15 |
two strains | 15 |
negative sense | 15 |
pcr primers | 15 |
specific nucleotide | 15 |
growth kinetics | 15 |
primer pair | 15 |
standard deviation | 15 |
enteric coronaviruses | 15 |
faecal samples | 15 |
fluorescence microscope | 15 |
related viruses | 15 |
approximately kb | 15 |
medium supplemented | 15 |
recombination event | 15 |
affinity chromatography | 15 |
inactivated virus | 15 |
modified bucyrus | 15 |
immunocompromised patients | 15 |
virus taxonomy | 15 |
ibv serotypes | 15 |
european bat | 15 |
may play | 15 |
hospitalized children | 15 |
sequences available | 15 |
limiting dilution | 15 |
tgev strains | 15 |
located within | 15 |
one group | 15 |
highly virulent | 15 |
hcv rna | 15 |
complete genomic | 15 |
igg titers | 15 |
first isolated | 15 |
recent study | 15 |
informed consent | 15 |
antigenic variants | 15 |
sv cells | 15 |
spleen cell | 15 |
plaque purified | 15 |
dna sequencing | 15 |
type isolates | 15 |
southern china | 15 |
vp vp | 15 |
diarrheal viruses | 15 |
thermo scientific | 15 |
antigenic determinants | 15 |
genome sequencing | 15 |
phylogenetic analyses | 15 |
ha activity | 15 |
without affinity | 15 |
evaluated using | 15 |
distress syndrome | 15 |
specific rna | 15 |
membrane proteins | 15 |
viruses associated | 15 |
cell extracts | 15 |
week old | 15 |
pigs inoculated | 15 |
tge virus | 15 |
exogenous cholesterol | 15 |
cell death | 15 |
partial rdrp | 15 |
small intestinal | 15 |
conserved region | 15 |
least two | 15 |
vn antibody | 15 |
infection rate | 15 |
virus yields | 15 |
antiviral response | 15 |
sequence similarities | 15 |
extracted rna | 15 |
also used | 15 |
virus isolate | 15 |
also demonstrated | 15 |
conserved among | 15 |
findings indicate | 15 |
nucleotide identity | 15 |
mouse monoclonal | 15 |
bootstrap replicates | 15 |
sequenced using | 15 |
bat cov | 15 |
sasa quelpaertensis | 15 |
pdcov rna | 15 |
cells via | 15 |
cell receptor | 15 |
associated virus | 15 |
using monoclonal | 14 |
virus culture | 14 |
performed according | 14 |
cycle sequencing | 14 |
genotype vii | 14 |
specific monoclonal | 14 |
viral glycoprotein | 14 |
samples using | 14 |
human parainfluenza | 14 |
expression cassette | 14 |
positive sense | 14 |
sequences obtained | 14 |
virus yield | 14 |
completely inhibited | 14 |
first passage | 14 |
reaction mixture | 14 |
new porcine | 14 |
pcv antibodies | 14 |
statistical significance | 14 |
blood monocytes | 14 |
primer sets | 14 |
hepcv antibodies | 14 |
stockholm agent | 14 |
virus release | 14 |
ibv infection | 14 |
multisystemic wasting | 14 |
strand cdna | 14 |
terminal domain | 14 |
natural infection | 14 |
gel shift | 14 |
protein complex | 14 |
surface glycoprotein | 14 |
prototype strain | 14 |
virus dna | 14 |
risk factors | 14 |
another study | 14 |
recently reported | 14 |
porcine aminopeptidase | 14 |
hemagglutination inhibition | 14 |
log tcid | 14 |
ssrna probes | 14 |
cell movement | 14 |
mebus strain | 14 |
cp strains | 14 |
common cold | 14 |
terminal amino | 14 |
sequence determination | 14 |
ha protein | 14 |
ppv replication | 14 |
virus vaccine | 14 |
significantly reduced | 14 |
approximately nm | 14 |
live virus | 14 |
time point | 14 |
bootstrap values | 14 |
positive controls | 14 |
coronavirus mhv | 14 |
point mutation | 14 |
disease viruses | 14 |
also known | 14 |
spot virus | 14 |
prcv tgev | 14 |
per well | 14 |
using polymerase | 14 |
excellent technical | 14 |
nasopharyngeal aspirates | 14 |
ion channel | 14 |
virus species | 14 |
virulent tgev | 14 |
tgev infection | 14 |
respiratory diseases | 14 |
may occur | 14 |
pathogen free | 14 |
feline kidney | 14 |
terminal end | 14 |
week intervals | 14 |
drug repositioning | 14 |
new species | 14 |
terminal half | 14 |
creative commons | 14 |
molecular dynamics | 14 |
new variants | 14 |
years ago | 14 |
febrile respiratory | 14 |
like bat | 14 |
major antigenic | 14 |
rna extracted | 14 |
coronavirus oc | 14 |
forming units | 14 |
rna isolation | 14 |
dmem containing | 14 |
coronavirus isolates | 14 |
mean monthly | 14 |
potassium cyanide | 14 |
viral load | 14 |
five times | 14 |
aa sequence | 14 |
inoculated orally | 14 |
least three | 14 |
virulent strain | 14 |
stalk domain | 14 |
penton base | 14 |
strain isolated | 14 |
cellular receptors | 14 |
molecular basis | 14 |
cp mice | 14 |
neutralizing epitope | 14 |
virus titre | 14 |
containing per | 14 |
nonstructural protein | 14 |
virus serotypes | 14 |
competitive binding | 14 |
many viruses | 14 |
borne viruses | 14 |
nonfatal cases | 14 |
thin sections | 14 |
sequences showed | 14 |
virus nucleocapsid | 14 |
rna shedding | 14 |
ci mmol | 14 |
internal control | 14 |
laboratory mice | 14 |
future studies | 14 |
cytoplasmic vacuoles | 14 |
ethics committee | 14 |
vp sequences | 14 |
infected rabbits | 14 |
method described | 13 |
peritoneal macrophages | 13 |
ph ire | 13 |
days pi | 13 |
human sars | 13 |
ck cells | 13 |
lipid rafts | 13 |
cholesterol depletion | 13 |
mesenteric lymph | 13 |
clinical trials | 13 |
corona virus | 13 |
designed based | 13 |
coronavirus hku | 13 |
reticulocyte lysate | 13 |
mortality rate | 13 |
coronavirus group | 13 |
secondary cases | 13 |
control piglets | 13 |
infectious doses | 13 |
united kingdom | 13 |
cell viability | 13 |
human rhinovirus | 13 |
genome characterization | 13 |
distantly related | 13 |
runde virus | 13 |
rabies viruses | 13 |
reverse genetics | 13 |
embryonic kidney | 13 |
fold increase | 13 |
control animals | 13 |
healthy controls | 13 |
simian virus | 13 |
estimating fifty | 13 |
ng ml | 13 |
pork industry | 13 |
may indicate | 13 |
considered statistically | 13 |
competition assay | 13 |
wide range | 13 |
strains used | 13 |
studies showed | 13 |
chicken embryos | 13 |
pcr reaction | 13 |
wide variety | 13 |
full length | 13 |
pathological changes | 13 |
transmembrane domain | 13 |
oligo ibv | 13 |
enter cells | 13 |
stock virus | 13 |
mice immunized | 13 |
gross lesions | 13 |
sensitive mutants | 13 |
mixed infection | 13 |
software version | 13 |
cleavage sites | 13 |
cell debris | 13 |
bat coronaviruses | 13 |
prrsv strain | 13 |
unique amino | 13 |
conventional rt | 13 |
ibv plp | 13 |
infection induces | 13 |
granulomatous lesions | 13 |
reverse primer | 13 |
taxonomic proposals | 13 |
coronavirus associated | 13 |
control cells | 13 |
copies ml | 13 |
humoral immune | 13 |
predicted amino | 13 |
detection signals | 13 |
ade activity | 13 |
human sapovirus | 13 |
infected monocytes | 13 |
ibv field | 13 |
entry process | 13 |
orf protein | 13 |
high titers | 13 |
stained cells | 13 |
canine parainfluenza | 13 |
xo activity | 13 |
pregnant sows | 13 |
infection resulted | 13 |
virus vaccines | 13 |
lamina propria | 13 |
ttt ttt | 13 |
antiviral drug | 13 |
nucleotide change | 13 |
seven days | 13 |
circular dna | 13 |
virus capsid | 13 |
results demonstrate | 13 |
mm hepes | 13 |
large numbers | 13 |
parvovirus infection | 13 |
rna polymerases | 13 |
protein complexes | 13 |
mini kit | 13 |
infected mouse | 13 |
sequence identities | 13 |
slippery sequence | 13 |
hare coltivirus | 13 |
four structural | 13 |
chronic hepatitis | 13 |
two separate | 13 |
surface expression | 13 |
natural killer | 13 |
embryonated chicken | 13 |
california hare | 13 |
proteins encoded | 13 |
investigated whether | 13 |
may affect | 13 |
ig cells | 13 |
cdna clones | 13 |
class i | 13 |
destroying enzyme | 13 |
rna genomes | 13 |
national center | 13 |
animals performed | 13 |
bat species | 13 |
iga antibody | 13 |
ch ldl | 13 |
viral agents | 13 |
light microscopy | 13 |
neutralization epitopes | 13 |
surface glycoproteins | 13 |
live attenuated | 13 |
classical strains | 13 |
human rotavirus | 13 |
old pigs | 13 |
bovine coronaviruses | 13 |
cervical lymph | 13 |
stool samples | 13 |
cell wall | 13 |
control mice | 13 |
permissive temperatures | 13 |
detection method | 13 |
acetic acid | 12 |
forward primer | 12 |
animal models | 12 |
cell type | 12 |
software package | 12 |
virus receptor | 12 |
lacrimal glands | 12 |
may result | 12 |
human ace | 12 |
jhm strain | 12 |
mutant viruses | 12 |
syncytia formation | 12 |
virus inoculation | 12 |
prrsv isolates | 12 |
atpase activity | 12 |
virus genomes | 12 |
higher titers | 12 |
also performed | 12 |
pedv subtypes | 12 |
sapovirus genotypes | 12 |
aichi virus | 12 |
mem containing | 12 |
genome replication | 12 |
pma treatment | 12 |
ge healthcare | 12 |
gp protein | 12 |
virus internalization | 12 |
gut contents | 12 |
putative recombination | 12 |
puerto rico | 12 |
binding properties | 12 |
virus molecular | 12 |
cells using | 12 |
tumor necrosis | 12 |
viral strains | 12 |
lead citrate | 12 |
mediated immunity | 12 |
also reported | 12 |
human sapoviruses | 12 |
step rt | 12 |
mrna transcription | 12 |
infected tissue | 12 |
antiviral agents | 12 |
monitored daily | 12 |
acute enteritis | 12 |
circulation rate | 12 |
korean strains | 12 |
like strain | 12 |
negative staining | 12 |
swab specimens | 12 |
agricultural university | 12 |
df cells | 12 |
feline calicivirus | 12 |
novel strain | 12 |
infection kinetics | 12 |
feline aminopeptidase | 12 |
viral diseases | 12 |
times higher | 12 |
end probe | 12 |
swine testicle | 12 |
antiviral state | 12 |
protective immunity | 12 |
virus propagation | 12 |
aligned using | 12 |
virus subtypes | 12 |
also revealed | 12 |
antigenic differences | 12 |
related bat | 12 |
hadv infection | 12 |
containing fetal | 12 |
four proteins | 12 |
first detection | 12 |
protein assay | 12 |
cells ml | 12 |
catalytic activity | 12 |
age group | 12 |
economic impact | 12 |
bronchitis coronavirus | 12 |
new variant | 12 |
previously shown | 12 |
one week | 12 |
specific mabs | 12 |
high level | 12 |
specimens collected | 12 |
dna extraction | 12 |
systematic review | 12 |
putative movement | 12 |
deletion mutant | 12 |
cellular membrane | 12 |
functional domains | 12 |
commercially available | 12 |
newly emerged | 12 |
round pcr | 12 |
abi prism | 12 |
avian coronaviruses | 12 |
tested using | 12 |
hev infection | 12 |
nucleotide differences | 12 |
tcid per | 12 |
western immunoblotting | 12 |
neutralizing monoclonal | 12 |
ssrna probe | 12 |
quelpaertensis nakai | 12 |
strain cv | 12 |
pcr purification | 12 |
pediatric patients | 12 |
cpn mice | 12 |
control groups | 12 |
haemorrhagic fever | 12 |
epizootic diarrhea | 12 |
tg ml | 12 |
transfected cells | 12 |
cells showed | 12 |
polyethylene glycol | 12 |
sucrose gradient | 12 |
significant increase | 12 |
jhm virus | 12 |
genomic characterization | 12 |
loop structure | 12 |
primary structure | 12 |
genus alphacoronavirus | 12 |
natural recombination | 12 |
tgev strain | 12 |
neutralization assay | 12 |
pedv isolate | 12 |
transport medium | 12 |
cell populations | 12 |
expression system | 12 |
commonly used | 12 |
influenza vaccines | 12 |
genes showed | 12 |
antigenic cross | 12 |
sample collection | 12 |
ma cells | 12 |
first week | 12 |
downregulated genes | 12 |
four major | 12 |
acid level | 12 |
conserved sequence | 12 |
red foxes | 12 |
pam cells | 12 |
viral genomes | 12 |
experimental studies | 12 |
histologic lesions | 12 |
mixed infections | 12 |
different serotypes | 12 |
passage level | 12 |
conserved motif | 12 |
hepcv isolates | 12 |
antibody production | 12 |
antigen expression | 12 |
membrane association | 12 |
one case | 12 |
interferon response | 12 |
infected st | 12 |
live pedv | 12 |
infected cp | 12 |
cell lysis | 12 |
bp fragment | 12 |
treponema pallidum | 12 |
well microtiter | 12 |
canine herpesvirus | 12 |
density gradient | 12 |
sigma chemical | 12 |
codon usage | 12 |
immune serum | 12 |
viral attachment | 12 |
may reflect | 12 |
intensive care | 12 |
virus using | 12 |
control measures | 12 |
binding motif | 12 |
field strain | 12 |
type species | 12 |
genetic recombination | 12 |
using anti | 12 |
results presented | 12 |
interspecies transmission | 12 |
previously published | 11 |
two chinese | 11 |
green monkey | 11 |
ph levels | 11 |
cruz biotechnology | 11 |
growth curves | 11 |
immune sera | 11 |
different times | 11 |
plant pathogens | 11 |
orally inoculated | 11 |
heparan sulfate | 11 |
ark dpi | 11 |
bat lyssavirus | 11 |
detection kit | 11 |
nested set | 11 |
weaned pigs | 11 |
less sensitive | 11 |
specific probes | 11 |
cell pellet | 11 |
virus variants | 11 |
new insights | 11 |
common viruses | 11 |
cell clones | 11 |
newly discovered | 11 |
im group | 11 |
human igg | 11 |
swe viruses | 11 |
rabbits inoculated | 11 |
rpmi medium | 11 |
contrast microscopy | 11 |
attenuated vaccines | 11 |
genetic variation | 11 |
observed among | 11 |
genetic heterogeneity | 11 |
mrna levels | 11 |
different cell | 11 |
protease domain | 11 |
subfamily paramyxovirinae | 11 |
licl treatment | 11 |
results demonstrated | 11 |
virus names | 11 |
fecal viral | 11 |
terminal side | 11 |
utr probes | 11 |
gnotobiotic calves | 11 |
rcv growth | 11 |
cfc cells | 11 |
four groups | 11 |
monthly temperature | 11 |
encoded proteins | 11 |
cdna clone | 11 |
fifty percent | 11 |
adenovirus serotype | 11 |
transmission electron | 11 |
protein structure | 11 |
pcr results | 11 |
six different | 11 |
wild type | 11 |
genetically diverse | 11 |
double stranded | 11 |
passage levels | 11 |
investigate whether | 11 |
cell membranes | 11 |
hmg domain | 11 |
rabbit igg | 11 |
swine infertility | 11 |
conjugated proteins | 11 |
specific activity | 11 |
variant strains | 11 |
real time | 11 |
virus samples | 11 |
tissue sections | 11 |
class ii | 11 |
microsomal membranes | 11 |
defective interfering | 11 |
intranasal inoculation | 11 |
human rhinoviruses | 11 |
nasal washes | 11 |
heat shock | 11 |
swab fluids | 11 |
athymic mice | 11 |
acute measles | 11 |
survival time | 11 |
bovine enterovirus | 11 |
genus coltivirus | 11 |
ldl i | 11 |
studies using | 11 |
field isolate | 11 |
animal viruses | 11 |
strain jhm | 11 |
supernatant fluids | 11 |
conformational change | 11 |
freshly isolated | 11 |
potential antiviral | 11 |
virus nonstructural | 11 |
domestic cats | 11 |
time course | 11 |
viral capsid | 11 |
recombinant porcine | 11 |
virus identification | 11 |
successfully isolated | 11 |
regression analysis | 11 |
different genotypes | 11 |
containing mm | 11 |
close relationship | 11 |
binding integrins | 11 |
gene analysis | 11 |
inducing neutralizing | 11 |
laboratory manual | 11 |
glial cultures | 11 |
west nile | 11 |
culture infectious | 11 |
rna species | 11 |
may serve | 11 |
fipv strains | 11 |
recombination detection | 11 |
detection rates | 11 |
viral hepatitis | 11 |
luminex xtag | 11 |
experimental conditions | 11 |
mcmv antigen | 11 |
pcr reactions | 11 |
strains may | 11 |
gastrointestinal tract | 11 |
year old | 11 |
infected patients | 11 |
egg yolk | 11 |
direct sequencing | 11 |
study period | 11 |
cells following | 11 |
nondenaturing page | 11 |
virus concentration | 11 |
cek cells | 11 |
viral structural | 11 |
mainland china | 11 |
viral polymerase | 11 |
relatively high | 11 |
using graphpad | 11 |
per reaction | 11 |
genetic characteristics | 11 |
swine influenza | 11 |
two additional | 11 |
ffu ml | 11 |
envelope proteins | 11 |
several different | 11 |
infected rats | 11 |
immunized sows | 11 |
sucrose gradients | 11 |
first described | 11 |
cellular proteins | 11 |
converting enzyme | 11 |
two independent | 11 |
rabbit serum | 11 |
study also | 11 |
detection methods | 11 |
binding ability | 11 |
nov gii | 11 |
well known | 11 |
viral enteritis | 11 |
using specific | 11 |
various viruses | 11 |
common differentially | 11 |
breeding colony | 11 |
nitrocellulose sheets | 11 |
normal mice | 11 |
expected size | 11 |
sera collected | 11 |
early stages | 11 |
ribosomal rna | 11 |
old embryonated | 11 |
mild mottle | 11 |
consensus sequences | 11 |
rflp patterns | 11 |
without trypsin | 11 |
simian hemorrhagic | 11 |
quantified using | 11 |
european isolates | 11 |
coronavirus disease | 11 |
lyssavirus type | 11 |
hemagglutinating activity | 11 |
pig sera | 11 |
different groups | 11 |
nile virus | 11 |
relatively small | 11 |
virus growth | 11 |
specific pcr | 11 |
virus grown | 11 |
sucrose density | 11 |
lamp method | 11 |
inoculated pig | 11 |
penaeus monodon | 11 |
pcr detection | 11 |
published sequences | 11 |
pedv reference | 11 |
sore throat | 11 |
worth noting | 11 |
nj culture | 11 |
viral rnas | 11 |
virus associated | 11 |
host immune | 11 |
causative agents | 11 |
clinical protection | 11 |
sqe treatment | 11 |
virus protein | 11 |
ha gene | 11 |
noncoding region | 11 |
epithelial cell | 11 |
influenza pandemic | 11 |
rna segment | 11 |
cov rna | 11 |
phase contrast | 11 |
fecal virus | 11 |
murine cytomegalovirus | 11 |
amplified dna | 11 |
research council | 11 |
see table | 11 |
rde activity | 11 |
binding element | 11 |
units ml | 11 |
leader sequence | 11 |
nucleotide sequencing | 10 |
bluetongue virus | 10 |
virus may | 10 |
day prior | 10 |
ha antigens | 10 |
cell tropism | 10 |
leucine zipper | 10 |
diarrheic calves | 10 |
subsequent passages | 10 |
pregnant gilts | 10 |
monocyte macrophage | 10 |
free water | 10 |
way antigenic | 10 |
primer sequences | 10 |
children less | 10 |
lamp assays | 10 |
strain florio | 10 |
broiler farms | 10 |
analysis indicated | 10 |
gel extraction | 10 |
healthy cats | 10 |
hi titers | 10 |
virus containing | 10 |
initial denaturation | 10 |
standard deviations | 10 |
days old | 10 |
plaque size | 10 |
supernatant fluid | 10 |
sporadic cases | 10 |
control pigs | 10 |
reduction neutralization | 10 |
villous epithelial | 10 |
intestinal epithelium | 10 |
korean sublineage | 10 |
low titers | 10 |
nasal shedding | 10 |
expression plasmid | 10 |
protein bands | 10 |
purified vp | 10 |
dependent replication | 10 |
type strain | 10 |
copy number | 10 |
old piglets | 10 |
pathogenic prrsv | 10 |
thermal cycler | 10 |
antibody detection | 10 |
among children | 10 |
brcv strains | 10 |
allantoic fluids | 10 |
reducing conditions | 10 |
virus structural | 10 |
hybrid peptides | 10 |
membrane cholesterol | 10 |
evolutionary distances | 10 |
carbonate buffer | 10 |
culture passage | 10 |
slab gels | 10 |
mumps virus | 10 |
buffered formalin | 10 |
positive strand | 10 |
antigenic relatedness | 10 |
human health | 10 |
various times | 10 |
unique among | 10 |
ark ibv | 10 |
murine noroviruses | 10 |
acute lower | 10 |
showed similar | 10 |
terminator cycle | 10 |
comparative studies | 10 |
cell monolayer | 10 |
dairy cattle | 10 |
different bat | 10 |
piglet serum | 10 |
canine infectious | 10 |
gav orf | 10 |
hepcv genome | 10 |
immune complexes | 10 |
washed times | 10 |
rdrp gene | 10 |
feline panleukopenia | 10 |
genome segments | 10 |
vaccine virus | 10 |
aa sequences | 10 |
pigs infected | 10 |
fatal disease | 10 |
animal care | 10 |
high sensitivity | 10 |
vaccine candidate | 10 |
spectrum antiviral | 10 |
broiler chickens | 10 |
virulent strains | 10 |
method using | 10 |
detection limits | 10 |
apparent molecular | 10 |
molecular evolution | 10 |
feline cells | 10 |
pig farms | 10 |
acid binding | 10 |
hsp family | 10 |
coronavirus isolated | 10 |
epidemiological studies | 10 |
cytomegalovirus infection | 10 |
euthymic mice | 10 |
cell cycle | 10 |
polymorphism analysis | 10 |
sample size | 10 |
porcine coronaviruses | 10 |
may represent | 10 |
different clinical | 10 |
partial characterization | 10 |
like proteinase | 10 |
mtt assay | 10 |
annealing temperature | 10 |
high titer | 10 |
two cases | 10 |
isolates formed | 10 |
showed clinical | 10 |
rna template | 10 |
herpesvirus type | 10 |
reverse primers | 10 |
porcine viperin | 10 |
membrane vesicles | 10 |
coding sequence | 10 |
specific iga | 10 |
cycling conditions | 10 |
total volume | 10 |
fixed cells | 10 |
asthma copd | 10 |
proteins may | 10 |
first round | 10 |
epigallocatechin gallate | 10 |
cov genome | 10 |
infantile gastroenteritis | 10 |
twofold dilutions | 10 |
species level | 10 |
three regions | 10 |
virus titration | 10 |
may cause | 10 |
well culture | 10 |
sequence comparisons | 10 |
binding region | 10 |
weeks post | 10 |
virus penetration | 10 |
shift assays | 10 |
obtained using | 10 |
experimentally inoculated | 10 |
also shown | 10 |
ray film | 10 |
viruses detected | 10 |
aborted fetuses | 10 |
tcids ml | 10 |
incubation period | 10 |
enteropathogenic coronavirus | 10 |
coronavirus avian | 10 |
inhibits prrsv | 10 |
oxide synthase | 10 |
fiber gene | 10 |
wasting disease | 10 |
circovirus type | 10 |
like illness | 10 |
taq dna | 10 |
antigenic properties | 10 |
solution containing | 10 |
specific neutralizing | 10 |
many countries | 10 |
weaning multisystemic | 10 |
serum neutralization | 10 |
novel human | 10 |
genetic relatedness | 10 |
cell ratios | 10 |
antiviral activities | 10 |
coxsackie virus | 10 |
coronavirus mouse | 10 |
tag tat | 10 |
typical clinical | 10 |
reference strain | 10 |
newly identified | 10 |
nt deletion | 10 |
co incubator | 10 |
whole genome | 10 |
positive results | 10 |
prepared using | 10 |
pdcov strain | 10 |
nasal swab | 10 |
th ts | 10 |
cellular immune | 10 |
bam hi | 10 |
previous findings | 10 |
laboratory rats | 10 |
mediated cell | 10 |
restriction sites | 10 |
nucleotide changes | 10 |
two novel | 10 |
human transmission | 10 |
three structural | 10 |
tissue homogenate | 10 |
inhibitory activity | 10 |
error bars | 10 |
massachusetts serotype | 10 |
acid change | 10 |
defense mechanisms | 10 |
protective immune | 10 |
rodent coronaviruses | 10 |
gene products | 10 |
binding domains | 10 |
south china | 10 |
two types | 10 |
results suggested | 10 |
infectious disease | 10 |
england biolabs | 10 |
alt activity | 10 |
equal volumes | 10 |
experimental reproduction | 10 |
sequences revealed | 10 |
nasopharyngeal swabs | 10 |
strain oh | 10 |
mcmv infected | 10 |
old mice | 10 |
equine viral | 10 |
primer set | 10 |
cells well | 10 |
ns gene | 10 |
medical research | 10 |
mouse cell | 10 |
genetic evolution | 10 |
subgenomic rna | 10 |
viral culture | 10 |
viral arteritis | 10 |
serially passaged | 10 |
control pig | 10 |
day intervals | 10 |
purified virions | 10 |
experimental inoculation | 10 |
tubular structures | 10 |
specific igm | 10 |
unpublished data | 10 |
partial sequences | 10 |
cytokine production | 10 |
acid extraction | 10 |
protein expressed | 10 |
glutathione sepharose | 10 |
ibdv vp | 10 |
using real | 10 |
industry worldwide | 10 |
grand island | 10 |
adenovirus hexons | 10 |
type strains | 10 |
glass slides | 10 |
bound ssrna | 10 |
free piglets | 10 |
rnp complex | 10 |
late stage | 10 |
vaccines based | 10 |
might also | 10 |
higher levels | 10 |
infect humans | 10 |
mucosal scrapings | 10 |
chronic infection | 10 |
new strain | 10 |
new york | 10 |
cd bcv | 10 |
genes encoding | 10 |
field virus | 10 |
pigs showed | 10 |
sepharose beads | 10 |
second group | 10 |
i virus | 10 |
effective vaccines | 10 |
lesser panda | 10 |
gene source | 10 |
icr mice | 10 |
plaque morphology | 10 |
infected monolayers | 10 |
genetically distinct | 10 |
fold differences | 10 |
low levels | 10 |
aa level | 9 |
macrophage lineage | 9 |
overlay medium | 9 |
bp long | 9 |
sodium monensin | 9 |
parent virus | 9 |
aa residues | 9 |
antibody positive | 9 |
associated herpesvirus | 9 |
unclassified mabs | 9 |
conditions used | 9 |
genus deltacoronavirus | 9 |
ii fipv | 9 |
cells expressing | 9 |
original pdcov | 9 |
virus assembly | 9 |
genetic variability | 9 |
vlp vaccine | 9 |
skim milk | 9 |
immune electron | 9 |
terminal sequences | 9 |
took place | 9 |
measles isolates | 9 |
clinical syndromes | 9 |
new strains | 9 |
mers outbreaks | 9 |
viruses may | 9 |
positive patients | 9 |
world health | 9 |
cloning kit | 9 |
genetic relationships | 9 |
major role | 9 |
among patients | 9 |
cell responses | 9 |
hexon genes | 9 |
interferon gamma | 9 |
first study | 9 |
serological relationship | 9 |
dnase i | 9 |
enteric tropism | 9 |
substitutions per | 9 |
isolates showed | 9 |
adenovirus infections | 9 |
types i | 9 |
ml trypsin | 9 |
kg body | 9 |
may contribute | 9 |
alkaline phosphatase | 9 |
highly hydrophobic | 9 |
outer layer | 9 |
vp region | 9 |
spike proteins | 9 |
infected cats | 9 |
innate immunity | 9 |
eukaryotic expression | 9 |
pulmonary disease | 9 |
normal mouse | 9 |
rabbit antiserum | 9 |
known coronaviruses | 9 |
acute febrile | 9 |
also obtained | 9 |
intracellular virus | 9 |
functional receptor | 9 |
population density | 9 |
conjugated secondary | 9 |
panleukopenia virus | 9 |
embryonated eggs | 9 |
atcc vr | 9 |
kind gift | 9 |
turkey poults | 9 |
infection studies | 9 |
inoculated i | 9 |
nucleotide level | 9 |
dbi isolate | 9 |
experiments using | 9 |
epidemic abortion | 9 |
saharan africa | 9 |
strain beaudette | 9 |
macrophages infected | 9 |
avc ire | 9 |
causes severe | 9 |
tannic acid | 9 |
blot hybridization | 9 |
porcine kobuvirus | 9 |
days prior | 9 |
putative cap | 9 |
culture media | 9 |
signal peptide | 9 |
susceptible cell | 9 |
nucleocapsid proteins | 9 |
phosphate dehydrogenase | 9 |
rabbit sera | 9 |
akt signaling | 9 |
female balb | 9 |
transcriptase pcr | 9 |
identified within | 9 |
enterococcus faecium | 9 |
pathogenic avian | 9 |
chicken embryo | 9 |
haemagglutination inhibition | 9 |
human herpesvirus | 9 |
brome mosaic | 9 |
routine pcr | 9 |
adult mice | 9 |
ge ml | 9 |
old female | 9 |
recombinant pedv | 9 |
natural populations | 9 |
rna sequences | 9 |
viruses using | 9 |
qiaquick pcr | 9 |
conserved motifs | 9 |
neutralizing mabs | 9 |
associated proteins | 9 |
protective effect | 9 |
pulmonary lesions | 9 |
cells transfected | 9 |
hepatitis viruses | 9 |
coated vesicles | 9 |
monolayer cultures | 9 |
animal disease | 9 |
hsp bind | 9 |
viral surface | 9 |
genome size | 9 |
vivo studies | 9 |
probably due | 9 |
virus groups | 9 |
family bunyaviridae | 9 |
cbv infection | 9 |
challenge virus | 9 |
bronchoalveolar lavage | 9 |
porcine rotavirus | 9 |
conformationally dependent | 9 |
virus nucleoprotein | 9 |
orf encodes | 9 |
glycoprotein cleavage | 9 |
thank drs | 9 |
parainfluenza viruses | 9 |
standard curve | 9 |
one another | 9 |
bootstrap support | 9 |
multiplex real | 9 |
respiratory symptoms | 9 |
high frequency | 9 |
nariva virus | 9 |
dnastar inc | 9 |
different levels | 9 |
bovine astrovirus | 9 |
virus envelope | 9 |
influenza season | 9 |
south america | 9 |
small number | 9 |
rna transcription | 9 |
throat swab | 9 |
hi tests | 9 |
copd patients | 9 |
rna helicase | 9 |
three strains | 9 |
fowl adenovirus | 9 |
expression vector | 9 |
electron density | 9 |
per dilution | 9 |
blind passages | 9 |
gamma interferon | 9 |
ts ratios | 9 |
swine herds | 9 |
canine viral | 9 |
produce ifn | 9 |
strains shared | 9 |
newly synthesized | 9 |
may lead | 9 |
classical ibvs | 9 |
od value | 9 |
small intestines | 9 |
first identified | 9 |
live vaccines | 9 |
neuraminidase inhibitors | 9 |
mutational analysis | 9 |
bca protein | 9 |
also examined | 9 |
important roles | 9 |
metapneumovirus infection | 9 |
secondary structures | 9 |
oral administration | 9 |
particles containing | 9 |
bovine embryonic | 9 |
hav rna | 9 |
cholesterol content | 9 |
comparative sequence | 9 |
breeding farms | 9 |
fecal suspension | 9 |
chronic obstructive | 9 |
analysis suggested | 9 |
cd strain | 9 |
applicable international | 9 |
protein band | 9 |
confirmed cases | 9 |
grant number | 9 |
modified eagle | 9 |
percent endpoints | 9 |
pfu per | 9 |
based assay | 9 |
one sample | 9 |
tyrosine phosphorylation | 9 |
gene showed | 9 |
control rats | 9 |
economically important | 9 |
different concentrations | 9 |
prrsv activity | 9 |
hemagglutinin esterase | 9 |
porcine sp | 9 |
rhinovirus serotypes | 9 |
respiratory pathogen | 9 |
low level | 9 |
amplified product | 9 |
three outbreaks | 9 |
well documented | 9 |
recombination analysis | 9 |
specific mab | 9 |
northern blot | 9 |
degenerate primers | 9 |
percent fbs | 9 |
evolutionary relationships | 9 |
humidified co | 9 |
mediated enhancement | 9 |
cross reaction | 9 |
health organization | 9 |
blast analysis | 9 |
rabbit antisera | 9 |
fatal cases | 9 |
ccv type | 9 |
mega software | 9 |
kresse isolate | 9 |
antibody technique | 9 |
bucyrus strain | 9 |
central region | 9 |
new method | 9 |
cent sucrose | 9 |
swab sample | 9 |
virus porcine | 9 |
containing fbs | 9 |
cv vaccine | 9 |
large rna | 9 |
virus specific | 9 |
potential glycosylation | 9 |
family members | 9 |
tcids per | 9 |
possible role | 9 |
median age | 9 |
equine rhinovirus | 9 |
murine leukemia | 9 |
fecv infection | 9 |
hubei province | 9 |
trees based | 9 |
infected frhk | 9 |
original virus | 9 |
analysis version | 9 |
master mix | 9 |
mature virions | 9 |
viral sequences | 9 |
mem supplemented | 9 |
restriction site | 9 |
survival rate | 9 |
pediatric pneumonia | 9 |
igg mabs | 9 |
african green | 9 |
epitope region | 9 |
pcv infection | 9 |
cdna using | 9 |
surfactant protein | 9 |
fluorescence intensity | 9 |
etiological agent | 9 |
eyach virus | 9 |
infection control | 9 |
virus dilution | 9 |
done using | 9 |
attenuated strain | 9 |
killer cells | 9 |
final volume | 9 |
nairobi sheep | 9 |
cfu ml | 9 |
pregnant women | 9 |
weight loss | 9 |
virus family | 9 |
mammalian species | 9 |
side chain | 9 |
prcv isolates | 9 |
asian countries | 9 |
produced using | 9 |
using two | 9 |
following i | 9 |
degradation products | 9 |
transferred onto | 9 |
pepper mild | 9 |
study provides | 9 |
intestinal mucosa | 9 |
antigenic groups | 9 |
data presented | 9 |
major cause | 9 |
hc ph | 9 |
rna samples | 9 |
avirulent derivate | 9 |
permissive temperature | 9 |
single amino | 9 |
developed diarrhea | 9 |
weeks later | 9 |
particle associated | 9 |
various concentrations | 9 |
intestinal tract | 9 |
lymphoid tissues | 9 |
growth factor | 9 |
nuclear localization | 9 |
rna copy | 9 |
structural genes | 9 |
human enterovirus | 9 |
natural compounds | 9 |